RCAR - RenovaCare, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

RenovaCare, Inc.

94 Hundred Corporate Center
9375 East Shea Boulevard Suite 107-A
Scottsdale, AZ 85260
United States

Full Time Employees1

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas BoldPres & Director100kN/A1961
Ms. Patsy J. TrislerVP of Regulatory & Clinical AffairsN/AN/A1948
Mr. Harmel S. RayatFounder, Chairman & CEON/AN/A1961
Mr. Steve Yan-KlassenChief Financial OfficerN/AN/AN/A
Mr. Jatinder Singh BhogalChief Operating OfficerN/AN/A1967
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


RenovaCare, Inc., a development-stage company, focuses on the acquisition, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System for spraying a patient's own skin stem cells onto burns and wounds for self-healing; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.

Corporate Governance

RenovaCare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.